October
Venture Capital & Private Equity London
Our Agenda
Private Equity, Venture Capital & Strategic Partnerships
What Are the Emerging Trends in Venture Capital for Drug Discovery and Biotech Startups?
Private Equity, Venture Capital & Strategic Partnerships
Early-Stage Science, Late-Stage Discipline: What Today’s Investors Want
Private Equity, Venture Capital & Strategic Partnerships
Strategic Alliances and Investment Strategies: Fueling the Future of Drug Discovery
Private Equity, Venture Capital & Strategic Partnerships
Partnering for Progress: How Big Pharma & Biotech Forge the Next Wave of Innovation
Private Equity, Venture Capital & Strategic Partnerships
Overcoming Investment Barriers in Biotech: R&D Costs, IP Issues, and Market Uncertainty
Private Equity, Venture Capital & Strategic Partnerships
How does biotech and pharma react to the geopolitcal changes and how does this affect collaboration and partnering strategies
Guido Koch,
CEO,
Amphilix
Private Equity, Venture Capital & Strategic Partnerships
How Strategic Partnerships Revolutionize Pharma R&D
Private Equity, Venture Capital & Strategic Partnerships
What Are the Emerging Trends in Venture Capital for Drug Discovery and Biotech Startups?
Private Equity, Venture Capital & Strategic Partnerships
The Role of Venture Partnerships in Drug Discovery
Private Equity, Venture Capital & Strategic Partnerships
Venture Strategies for Biotech Startups: Building Scalable Innovations in Drug Discovery
Engage in Real Conversations That Matter
Our unique roundtable format fosters meaningful dialogue—not lectures—so you gain actionable insights from every discussion. Choose up to four roundtable sessions, each limited to 20 participants, and connect with senior-level peers in a relaxed, collaborative setting.
Further Information
Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch
Here To Help
Need help registering your team? Just get in touch and a member of the team will be happy to help.